Stocks and Investing
Stocks and Investing
Fri, February 10, 2012
[ 08:47 AM ] - Market Wire
[ 07:41 AM ] - WOPRAI
[ 07:41 AM ] - WOPRAI
[ 07:41 AM ] - WOPRAI
[ 07:40 AM ] - WOPRAI
[ 07:40 AM ] - WOPRAI
[ 07:40 AM ] - WOPRAI
[ 07:40 AM ] - WOPRAI
[ 07:40 AM ] - WOPRAI
[ 06:00 AM ] - Market Wire
[ 06:00 AM ] - Market Wire
[ 05:40 AM ] - WOPRAI
[ 05:40 AM ] - WOPRAI
[ 05:40 AM ] - WOPRAI
[ 01:22 AM ] - WOPRAI
[ 01:22 AM ] - WOPRAI
[ 01:21 AM ] - WOPRAI
[ 01:21 AM ] - WOPRAI
[ 01:20 AM ] - WOPRAI
[ 01:20 AM ] - WOPRAI
[ 01:20 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Matthew Harrison Initiated (BIIB) at Buy and Held Target at $140 on, Feb 10th, 2012
Matthew Harrison of Morgan Stanley, Initiated "Biogen Inc." (BIIB) at Buy and Held Target at $140 on, Feb 10th, 2012.
Matthew, nor any peers, have made any analyst calls on BIIB in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30